Abstract
Mast cells and basophils play a crucial role during type I hypersensitivity reactions. However, despite efforts to elucidate their role in the pathogenesis of allergy and inflammation, our understanding of mast cell and basophil biology is still relatively scarce. The practical difficulty in obtaining a sufficient number of purified primary cells from biological samples has slowed down the process of reaching a full understanding of the physiological role of these functionally similar cell types. The establishment of several immortalized cell lines has been a useful tool to establish and perform sophisticated laboratory protocols that are impractical using primary cells. Continuous cell lines have been extensively used to investigate the allergen/IgE-mediated cell activation, to elucidate the degranulation dynamics, to investigate structural and functional properties of the high-affinity receptor (FcεRI), and to test cell-stabilizing compounds. In this chapter we review the most widely used and better characterized mast cell and basophil cell lines, highlighting their advantages and drawbacks. It must be pointed out, however, that while cell lines represent a useful in vitro tool due to their easy manipulability and reduced culture costs, they often show aberrant characteristics which are not fully representative of primary cell physiology; results obtained with such cells therefore must be interpreted with due care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Vogel L, Lüttkopf D, Hatahet L et al (2005) Development of a functional in vitro assay as a novel tool for the standardization of allergen extracts in the human system. Allergy 60:1021–1028
Lin J, Renault N, Haas H et al (2007) A novel tool for the detection of allergic sensitization combining protein microarrays with human basophils. Clin Exp Allergy 37:1854–1862
Ladics GS, van Bilsen JHM, Brouwer HMH et al (2008) Assessment of three human FcepsilonRI-transfected RBL cell-lines for identifying IgE induced degranulation utilizing peanut-allergic patient sera and peanut protein extract. Regul Toxicol Pharmacol 51:288–294
Gelbmann CM, Mestermann S, Gross V et al (1999) Strictures in Crohn’s disease are characterised by an accumulation of mast cells colocalised with laminin but not with fibronectin or vitronectin. Gut 45:210–217
Raithel M, Winterkamp S, Pacurar A et al (2001) Release of mast cell tryptase from human colorectal mucosa in inflammatory bowel disease. Scand J Gastroenterol 36:174–179
Dvorak AM, Monahan RA, Osage JE et al (1980) Crohn’s disease: transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum Pathol 11:606–619
Bischoff SC (2007) Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data. Nat Rev Immunol 7:93–104
Supajatura V, Ushio H, Nakao A et al (2002) Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J Clin Invest 109:1351–1359
Puxeddu I, Piliponsky AM, Bachelet I, Levi-Schaffer F (2003) Mast cells in allergy and beyond. Int J Biochem Cell Biol 35:1601–1607
Dawicki W, Marshall JS (2007) New and emerging roles for mast cells in host defence. Curr Opin Immunol 19:31–38
Brunner T, Heusser CH, Dahinden CA (1993) Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J Exp Med 177:605–611
Eccleston E, Leonard BJ, Lowe JS et al (1973) Basophilic leukaemia in the albino rat and a demonstration of the basopoietin. Nat New Biol 244:73–76
Passante E, Frankish N (2009) The RBL-2H3 cell line: its provenance and suitability as a model for the mast cell. Inflamm Res 58:737–745
Butterfield JH, Weiler D, Dewald G et al (1988) Establishment of an immature mast cell line from a patient with mast cell leukemia. Leuk Res 12:345–355
Kirshenbaum AS, Akin C, Wu Y et al (2003) Characterization of novel stem cell factor responsive human mast cell lines LAD 1 and 2 established from a patient with mast cell sarcoma/leukemia; activation following aggregation of FcεRI or FcγRI. Leuk Res 27:677–682
Laidlaw TM, Steinke JW, Tiñana AM et al (2011) Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI. J Allergy Clin Immunol 127:815–822
Nilsson G, Blom T, Kusche-Gullberg M et al (1994) Phenotypic characterization of the human mast-cell line HMC-1. Scand J Immunol 39:489–498
Sundström M, Vliagoftis H, Karlberg P et al (2003) Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene. Immunology 108:89–97
Edling CE, Hallberg B (2007) c-Kit-a hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol 39:1995–1998
Furitsu T, Tsujimura T, Tono T et al (1993) Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 92:1736–1744
Worobec AS, Semere T, Nagata H et al (1998) Clinical correlates of the presence of the Asp816Val c-kit mutation in the peripheral blood mononuclear cells of patients with mastocytosis. Cancer 83:2120–2129
Longley BJ, Metcalfe DD, Tharp M et al (1999) Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis. Proc Natl Acad Sci U S A 96:1609–1614
Cruse G, Kaur D, Leyland M et al (2010) A novel FcεRIβ-chain truncation regulates human mast cell proliferation and survival. FASEB J 24:4047–4057
Xia YC, Sun S, Kuek LE et al (2011) Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production. Int Immunopharmacol 11:1002–1011
Guhl S, Babina M, Neou A et al (2010) Mast cell lines HMC-1 and LAD2 in comparison with mature human skin mast cells-drastically reduced levels of tryptase and chymase in mast cell lines. Exp Dermatol 19:845–847
Kishi K (1985) A new leukemia cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 9:381–390
Yamashita M, Ichikawa A, Katakura Y et al (2001) Induction of basophilic and eosinophilic differentiation in the human leukemic cell line KU812. Cytotechnology 36:179–186
Fukuda T, Kishi K, Ohnishi Y et al (1987) Bipotential cell differentiation of KU812: evidence of a hybrid cell line that differentiates into basophils and macrophage-like cells. Blood 70:612–619
Fischkoff SA, Kishi K, Benjamin WR et al (1987) Induction of differentiation of the human leukemia cell line, KU812. Leuk Res 11:1105–1113
Blom T, Huang R, Aveskogh M et al (1992) Phenotypic characterization of KU812, a cell line identified as an immature human basophilic leukocyte. Eur J Immunol 22:2025–2032
Magnusson CG, Håård J, Matsson P et al (1995) Demonstration of specific high-affinity Fc epsilon-receptors on the human basophil-like leukemia cell line KU812 by flow cytometry. Allergy 50:72–77
Almlöf I, Nilsson K, Johansson V, Akerblom E, Slotte H, Ahlstedt S, Matsson P (1988) Induction of Basophilic Differentiation in the Human Basophilic Cell Line KU812. Scand J Immunol 28:293–300
Nilsson G, Carlsson M, Jones I et al (1994) TNF-alpha and IL-6 induce differentiation in the human basophilic leukaemia cell line KU812. Immunology 81:73–78
Hutt-Taylor SR, Harnish D, Richardson M et al (1988) Sodium butyrate and a T lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukemia cell line HL-60. Blood 71:209–215
Valent P, Besemer J, Kishi K et al (1990) IL-3 promotes basophilic differentiation of KU812 cells through high affinity binding sites. J Immunol 145:1885–1889
Nakazawa M, Mitjavila MT, Debili N et al (1989) KU 812: a pluripotent human cell line with spontaneous erythroid terminal maturation. Blood 73:2003–2013
Valent P, Besemer J, Sillaber C et al (1990) Failure to detect IL-3-binding sites on human mast cells. J Immunol 145:3432–3437
Razin E, Ihle JN, Seldin D et al (1984) Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. J Immunol 132:1479–1486
Dearman RJ, Skinner RA, Deakin N, Shaw D, Kimber I (2005) Evaluation of an in vitro method for the measurement of specific IgE antibody responses: the rat basophilic leukemia (RBL) cell assay. Toxicology 206:195–205
Kulczycki A, Metzger H (1974) The interaction of IgE with rat basophilic leukemia cells. II Quantitative aspects of the binding reaction. J Exp Med 140:1676–1695
Rashid A, Sadroddiny E, Ye HT et al (2012) Review: Diagnostic and therapeutic applications of rat basophilic leukemia cells. Mol Immunol 52:224–228
Holowka D, Hartmann H, Kanellopoulos J et al (1980) Association of the receptor for immunoglobulin E with an endogenous polypeptide on rat basophilic leukemia cells. J Recept Res 1:41–68
Goetze A, Kanellopoulos J, Rice D et al (1981) Enzymatic cleavage products of the alpha subunit of the receptor for immunoglobulin E. Biochemistry 20:6341–6349
Kraft S, Kinet J-P (2007) New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol 7:365–378
Ra C, Jouvin MH, Kinet JP (1989) Complete structure of the mouse mast cell receptor for IgE (Fc epsilon RI) and surface expression of chimeric receptors (rat-mouse-human) on transfected cells. J Biol Chem 264:15323–15327
Akizawa Y (2003) Regulation of human FcepsilonRI beta chain gene expression by Oct-1. Int Immunol 15:549–556
Hara T, Yamada K, Tachibana H (1998) Basophilic differentiation of the human leukemia cell line KU812 upon treatment with interleukin-4. Biochem Biophys Res Commun 247:542–548
Gilfillan AM, Kado-Fong H, Wiggan GA et al (1992) Conservation of signal transduction mechanisms via the human Fc epsilon RI alpha after transfection into a rat mast cell line, RBL 2H3. J Immunol 149:2445–2451
Takagi K, Nakamura R, Teshima R et al (2003) Application of human Fc epsilon RI alpha-chain-transfected RBL-2H3 cells for estimation of active serum IgE. Biol Pharm Bull 26:252–255
Passante E, Ehrhardt C, Sheridan H et al (2009) RBL-2H3 cells are an imprecise model for mast cell mediator release. Inflamm Res 58:611–618
Hoffmann A, Jamin A, Foetisch K et al (1999) Determination of the allergenic activity of birch pollen and apple prick test solutions by measurement of beta-hexosaminidase release from RBL-2H3 cells. Comparison with classical methods in allergen standardization. Allergy 54:446–454
Galli SJ, Nakae S, Tsai M (2005) Mast cells in the development of adaptive immune responses. Nat Immunol 6:135–142
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Passante, E. (2014). Mast Cell and Basophil Cell Lines: A Compendium. In: Gibbs, B., Falcone, F. (eds) Basophils and Mast Cells. Methods in Molecular Biology, vol 1192. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1173-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1173-8_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1172-1
Online ISBN: 978-1-4939-1173-8
eBook Packages: Springer Protocols